Skip to content

To compare safety and clinical outcome of different intraocular delivery system in patients with cataract

Prospective, comparative, multicentric, randomized, post-marketing clinical study involving three intraocular lens (IOL) delivery system. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089539
Enrollment
111
Registered
2025-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Eyecryl sert pre-loaded delivery intraocular lens: EYECRYL SERT is a pre-loaded, Aspheric Natural Yellow acrylic, foldable, single piece posterior chamber EDOF (extended depth of foc

Sponsors

Biotech vision care pvt ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older 2. Good general and ocular health who had a cataract in one eye or both eyes 3. Patients willing to attend all follow-up appointments 4. Patients must sign and be given a copy of the written Informed Consent form 5. Patients willing comply with the study procedures 6. Female participants of child bearing potential and male participants whose partner is of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study

Exclusion criteria

Exclusion criteria: 1. Systemic disease that affect the cornea 2. Inflammation or edema of the cornea 3. Previous corneal treatment 4. Previous retinal detachment 5. Pregnancy or lactation 6. Any condition observed before or during surgery that may affect the success of the cataract surgery 7. Evidence of trauma on bio microscopic examination 8. Participated in any study during the use of the study device 9. Vulnerable population 10. Corneal astigmatism greater than 1D.

Design outcomes

Primary

MeasureTime frame
To evaluate safety in patients implanted with different intraocular lens delivery systems.Timepoint: intra- operative, day 1 and day 30 7 days post-surgery or as and when occurs

Secondary

MeasureTime frame
To evaluate clinical acceptability, delivery characteristics and clinical outcomes in patients implanted with different intraocular lens delivery systems.Timepoint: intra- operative, day 1 and day 30 7 days post-surgery or as and when occurs

Countries

India

Contacts

Public ContactBhargav Joshi

BIOTECH VISION CARE PVT LTD

bhargav.joshi@biotechhealthcare.com09925925667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026